Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01972217
Title Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications

prostate cancer

Therapies

Prednisone

Abiraterone

Olaparib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL


No variant requirements are available.